144
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects

, , &
Pages 517-525 | Published online: 26 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maria Fernanda Delgado, Ahmed Mostafa Abdelrahman, Malika Terahi, Juan Jose Miro Quesada Woll, Felix Gil-Carrasco, Colin Cook, Mohamed Benharbit, Sebastien Boisseau, Ernestine Chung, Yacine Hadjiat & José AP Gomes. (2019) Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement. ClinicoEconomics and Outcomes Research 11, pages 591-604.
Read now
Nurgül Örnek & Kemal Örnek. (2018) The use of selective laser trabeculoplasty to treat glaucoma. Expert Review of Ophthalmology 13:4, pages 191-204.
Read now
Marisa Meloni, Giampiero Cattaneo & Barbara De Servi. (2012) Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications. Clinical Ophthalmology 6, pages 1433-1440.
Read now

Articles from other publishers (18)

Xiaoyu Zhou, Xinyue Zhang, Dengming Zhou, Yang zhao & Xuanchu Duan. (2022) A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications. Ophthalmology and Therapy 11:5, pages 1681-1704.
Crossref
Elizabeta Marceta & Dusan Todorovic. (2021) The Effect of Glaucoma on the Quality of Patient’s Life. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Adriano Guarnieri, Elena Carnero, Anne-Marie Bleau, Belén Alfonso-Bartolozzi & Javier Moreno-Montañés. (2019) Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients. International Ophthalmology 40:3, pages 741-751.
Crossref
Rodolfo Mastropasqua, Luca Agnifili & Leonardo Mastropasqua. (2019) Structural and Molecular Tear Film Changes in Glaucoma. Current Medicinal Chemistry 26:22, pages 4225-4240.
Crossref
Francisco Pérez-Bartolomé, Jose María Martínez de la Casa, Pedro Arriola-Villalobos, Cristina Fernández-Pérez & Julián García-Feijoó. (2018) Intraocular light scatter in patients on topical intraocular pressure–lowering medication. European Journal of Ophthalmology 28:6, pages 652-661.
Crossref
Myrjam De Keyser, Maya De Belder, Jonas De Belder & Veva De Groot. (2018) Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients. Acta Ophthalmologica 96:5, pages e577-e581.
Crossref
Kristin Schmid Biggerstaff & Albert Lin. (2018) Glaucoma and Quality of Life. International Ophthalmology Clinics 58:3, pages 11-22.
Crossref
Francisco Pérez-Bartolomé, Jose M. Martínez-de-la-Casa, Pedro Arriola-Villalobos, Cristina Fernández-Pérez, Vicente Polo & Julián García-Feijoó. (2017) Ocular Surface Disease in Patients under Topical Treatment for Glaucoma. European Journal of Ophthalmology 27:6, pages 694-704.
Crossref
Ichiro Kawaguchi, Akira Kobayashi, Tomomi Higashide, Yasuhiro Takeji, Kazushi Sakurai, Chiaki Kawaguchi & Kazuhisa Sugiyama. (2017) Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits. PLOS ONE 12:10, pages e0186714.
Crossref
Tan Ee Ling, Khairuddin Othman, Ong Poh Yan, Rasdi Abdul Rashid, Cheong Min Tet, Azhany Yaakob & Liza-Sharmini Ahmad Tajudin. (2017) Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure. The Open Ophthalmology Journal 11:1, pages 31-39.
Crossref
Naoto Tokuda, Yasushi Kitaoka, Akiko Matsuzawa, Ayaka Tsukamoto, Kana Sase, Shinsuke Sakae & Hitoshi Takagi. (2017) Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost. Journal of Ophthalmology 2017, pages 1-6.
Crossref
Sibel Kocabeyoglu, MehmetC Mocan & Murat Irkec. (2015) Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues. Indian Journal of Ophthalmology 63:1, pages 15.
Crossref
Naoto Tokuda, Yasushi Kitaoka, Akiko Matsuzawa, Junsuke Miyamoto, Shinsuke Sakae, Yasunari Munemasa & Hitoshi Takagi. (2015) The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients. Journal of Ophthalmology 2015, pages 1-5.
Crossref
Ja Young YouByung Joo Cho. (2013) Effect of Latanoprost on Central Corneal Thickness in Unilateral Normal-Tension Glaucoma. Journal of Ocular Pharmacology and Therapeutics 29:3, pages 335-338.
Crossref
Zane Anwar, Sarah R. Wellik & Anat Galor. (2013) Glaucoma therapy and ocular surface disease. Current Opinion in Ophthalmology 24:2, pages 136-143.
Crossref
R. Giménez-Gómez, M.R. García-Catalán & J.M. Gallardo-Galera. (2013) Tear clearance and ocular symptoms in patients treated with preservative-free prostaglandins. Archivos de la Sociedad Española de Oftalmología (English Edition) 88:3, pages 88-91.
Crossref
R. Giménez-Gómez, M.R. García-Catalán & J.M. Gallardo-Galera. (2013) Aclaramiento lagrimal y sintomatología ocular en pacientes tratados con prostaglandinas sin conservantes. Archivos de la Sociedad Española de Oftalmología 88:3, pages 88-91.
Crossref
Snježana Kaštelan, Martina Tomić, Kata Metež Soldo & Jasminka Salopek-Rabatić. (2013) How Ocular Surface Disease Impacts the Glaucoma Treatment Outcome. BioMed Research International 2013, pages 1-7.
Crossref